NCT05230043

Brief Summary

The study authors hypothesize a combination of cognitive, brain structural, brain functional and brain connectivity impairments in Suicide Attempters compared to Patient Controls and Healthy Controls, with deficits more marked in suicide attempters using violent suicidal means including:

  1. 1.Impaired choices at the reversal learning task with responses influenced by immediate outcome. This deficit would be correlated with brain activity in ventromedial Prefrontal Cortex during resting state and with several peripheral markers of the 5HT-system.
  2. 2.Reduced loss aversion. These deficits would be related to altered dynamics of Blood-Oxygen Level Dependent signal in the dorsal and ventral striatum as well as in ventral Prefrontal Cortex/ orbitofrontal cortex during the loss aversion task. These deficits would also be correlated with several peripheral markers of the 5HT-system.
  3. 3.Increased pain tolerance facilitating the execution of a violent and possibly painful act. These deficits measured with the algometer would be correlated with several peripheral markers of the 5HT-system.
  4. 4.Reduced behavioral inhibition in aversive context at the orthogonalized GoNoGo task facilitating the choice of a violent means. These deficits would be associated with altered Blood-Oxygen Level Dependent signal in ventral Prefrontal Cortex/ orbitofrontal cortex and parietal cortex during the resting state and correlated with several peripheral markers of the 5HT-system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 21, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2023

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2023

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

1.5 years

First QC Date

January 28, 2022

Last Update Submit

December 3, 2025

Conditions

Keywords

Neuroimagingdecision-making

Outcome Measures

Primary Outcomes (1)

  • Brain activity between groups

    Magnetic Resonance Imaging signal during the resting state and loss aversion task Blood-Oxygen Level Dependent sequences.

    Day 0

Secondary Outcomes (4)

  • Impaired reversal learning between groups

    Day 0

  • Loss aversion between groups

    Day 1

  • Pain tolerance between groups

    Day 0

  • Behavioral inhibition in aversive context between groups

    Day 0

Study Arms (4)

Suicide Attempters using Violent Means

A violent suicidal act is any suicidal act conducted with any means except for medication overdose or superficial wrist cutting.

Other: Algometer testOther: functional MRI

Patient Control

Other: Algometer testOther: functional MRI

Healthy Controls

Other: Algometer testOther: functional MRI

Suicide Attempters not using Violent Means

Other: Algometer testOther: functional MRI

Interventions

The computerized pressure algometer, AlgoMed (Medoc, Ramat Yishai, Israel), will be used for mechanical pain stimulation to assess information about pain threshold and tolerance. A constant rate of pressure is delivered by the examiner, and the pressure is recorded in Kilopascal (kPa). The stimulation will be applied between the medial and distal joints of the phalanges of the dominant hand.

Healthy ControlsPatient ControlSuicide Attempters not using Violent MeansSuicide Attempters using Violent Means

* Two 8s sequences of spin echo field map with phase encoding AP and PA * A 12:00min bold sequence for resting-state * A 15:12min bold sequence for gambling task thickness=2mm, Matrix Size = 105×105, FOV=210×210mm2; * A 6:38min T1w MPR sequence * A 7:40min T1w MPR sequence * A 5:57min T2w SPC sequence * A 8:24min T2w SPC sequence * A 8:32min FLAIR T2w sequence * Two 8:26min Multi-echo GRE sequence * A 8:29min high resolution multi-echo GRE sequence * Two 6:46min multi-echo GRE sequence with and without magnetic transfer contrast * Two 6:03min diffusion weighted images with phase encoding AP and PA

Healthy ControlsPatient ControlSuicide Attempters not using Violent MeansSuicide Attempters using Violent Means

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Four groups of participants will be recruited: 1. 20 individuals with personal history of mood disorder (bipolar disorder or depressive disorders) and at least one suicidal act committed with a violent means within the last 12 months. 2. 20 individuals with personal history of mood disorder (bipolar disorder or depressive disorders) and at least one suicidal act conducted within the last 12 months but no lifetime history of suicidal act with a violent means. 3. 20 individuals with personal history of mood disorder (bipolar disorder or depressive disorders) who never attempted suicide and have no family history of suicidal behavior up to the second biological degree. 4. 20 individuals with no personal history of major mental disorder or suicidal act and no family history of suicidal behavior up to the second biological degree.

You may qualify if:

  • Right-handed (as assessed with the Edinburgh Handedness Scale).
  • Agreement to participate and sign the informed consent form.
  • Is insured or beneficiary of a health insurance plan.
  • Speaks French.
  • Suicide Attempters using Violent Means group:
  • a personal history of mood disorder (bipolar disorder or depressive disorders according to DSM-5 criteria measured with the MINI 7.0);
  • at least one suicidal act committed with a violent means within the last 5 years.
  • Suicide Attempters using Non-Violent Means group:
  • a personal history of mood disorder (bipolar disorder or depressive disorders according to DSM-5 criteria measured with the MINI 7.0);
  • at least one suicidal act conducted within the last 5 years;
  • no lifetime history of suicidal act with a violent means.
  • Patient Control group:
  • a personal history of mood disorder (bipolar disorder or depressive disorders according to DSM-5 criteria measured with the MINI 7.0);
  • never attempted suicide in their lifetime;
  • no family history of suicidal behavior up to the second biological degree.
  • +4 more criteria

You may not qualify if:

  • Currently under judicial protection, or under adult guardianship.
  • Refusal to participate.
  • Is pregnant or breast feeding.
  • The suicide attempt may have impacted the brain functioning (e.g. following hanging, asphyxia by drowning, head trauma following jumping from height, bullet impact, etc). This criteria will be assessed clinically by the investigator.
  • Mental retardation (known or observed during the interview).
  • Current psychotic disorder (according to the MINI 7.0).
  • Current hypomanic episode (according to the MINI 7.0).
  • Current manic, mixed, rapid cycling episodes (according to the MINI 7.0).
  • Alcohol or substance disorder within last 3 months (according to the MINI 7.0).
  • Past major brain trauma (with loss of consciousness \> 1 minute).
  • Contra-indication to MRI (metal in body (including due to suicidal act), claustrophobia, impossibility to lie still on the back during one hour).
  • Electroconvulsive therapy within the last three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nimes

Nîmes, France

Location

Related Publications (1)

  • Jollant F, Leon C. Suicidal transition rates and their predictors in the adult general population: a repeated survey over 21 years in France. Eur Psychiatry. 2024 Oct 29;67(1):e74. doi: 10.1192/j.eurpsy.2024.1782.

Biospecimen

Retention: SAMPLES WITH DNA

Blood and hair samples

MeSH Terms

Conditions

Suicide, Attempted

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Fabrice Jollant

    CHU Nimes

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2022

First Posted

February 8, 2022

Study Start

March 21, 2022

Primary Completion

September 8, 2023

Study Completion

September 20, 2023

Last Updated

December 10, 2025

Record last verified: 2025-12

Locations